熊本大学 - Kumamoto University
熊本大学大学院生命科学研究部 代謝内科学分野
  • 臨床
  • 研究
  • 募集
ホーム > 研究 > 業績

業績

代謝内科学業績集(欧文原著)

代謝内科学業績集(欧文著書)

2017年

  • Araki E, Onishi Y, Asano M, Kim H, Yajima T: Efficacy and safety of dapagliflozin over 1 year as add-on to insulin therapy in Japanese patients with type 2 diabetes: DAISY trial. Diabetes Obes Metab 19:562-570, 2017.
  • Araki E, Haneda M, Kasuga M, Nishikawa T, Kondo T, Ueki K, Kadowaki T: New glysemic targets for patients with diabetes from the Japan Diabetes Society. J Diabetes Investig 8(1):123-125, 2017.
  • Sakaguchi M, Fujisaka S, Cai W, Winnay JN, Konishi M, O'Neill BT, Li M, García-Martín R, Takahashi H, Hu J, Kulkarni RN, KahnCR: Adipocyte Dynamics and Reversible Metabolic Syndrome in Mice with an Inducible Adipocyte-Specific Deletion of the Insulin Receptor. Cell Metab 25(2):448-462, 2017.
  • Thomou T, Mori MA, Dreyfuss JM, Konishi M, Sakaguchi M, Wolfrum C, Rao TN, Winnay JN, Garcia-Martin R, Grinspoon SK, Gorden P, Kahn CR: Adipose-derived circulating miRNAs regulate gene expression in other tissues. Nature 542:450-455, 2017.
  • Arai H, Yamashita S, Yokote K, Araki E, Suganami H, Ishibashi S, on behalf of the K-877 Study Group: Efficacy and safety of K-877, a novel selective peroxisome proliferator-activated receptor α modulator (SPPARMα), in combination with statin treatment: Two randomised, double-blind, placebo-controlled clinical trials in patients with dyslipidaemia. Atherosclerosis. 2017, in press.
  • Nakamura J, Kamiya H, Haneda M, Inagaki N, Tanizawa Y, Araki E, Ueki K, Nakayama T: Causes of death in Japanese patients with diabetes based on the results of a survey of 45,708 cases during 2001-2010: Report of the Committee on Causes of Death in Diabetes Mellitus. J Diabetes Investig 2017, in press.
  • Kajihara N, Kukidome D, Sada K, Motoshima H, Furukawa N, Matsumura T, Nishikawa T, Araki E: Low glucose induces mitochondrial reactive oxygen species via fatty acid oxidation in bovine aortic endothelial cells. J Diabetes Investig 2017, in press.